Skip to main content
Erschienen in: Intensive Care Medicine 7/2016

03.05.2016 | Correspondence

Is antithrombin III for sepsis-associated disseminated intravascular coagulation really ineffective?

verfasst von: Toshiaki Iba, Jecko Thachil

Erschienen in: Intensive Care Medicine | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Literatur
1.
Zurück zum Zitat Allingstrup M, Wetterslev J, Ravn FB et al (2016) Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. doi:10.1007/s00134-016-4225-7 PubMed Allingstrup M, Wetterslev J, Ravn FB et al (2016) Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. doi:10.​1007/​s00134-016-4225-7 PubMed
2.
Zurück zum Zitat Umemura Y, Yamakawa K, Ogura H et al (2015) Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost 13:1–13 Umemura Y, Yamakawa K, Ogura H et al (2015) Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost 13:1–13
3.
Zurück zum Zitat Warren BL, Eid A, Singer P et al (2001) Caring for the critically ill patient. High-dose antithrombin III in severe sepsis, a randomized controlled trial. JAMA 286:1869–1878CrossRefPubMed Warren BL, Eid A, Singer P et al (2001) Caring for the critically ill patient. High-dose antithrombin III in severe sepsis, a randomized controlled trial. JAMA 286:1869–1878CrossRefPubMed
4.
Zurück zum Zitat Kienast J, Juers M, Wiedermann CJ et al (2006) Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 4:90–97CrossRefPubMed Kienast J, Juers M, Wiedermann CJ et al (2006) Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 4:90–97CrossRefPubMed
5.
Zurück zum Zitat Tagami T, Matsui H, Horiguchi H et al (2014) Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study. J Thromb Haemost 12:1470–1479CrossRefPubMed Tagami T, Matsui H, Horiguchi H et al (2014) Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study. J Thromb Haemost 12:1470–1479CrossRefPubMed
Metadaten
Titel
Is antithrombin III for sepsis-associated disseminated intravascular coagulation really ineffective?
verfasst von
Toshiaki Iba
Jecko Thachil
Publikationsdatum
03.05.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 7/2016
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-016-4288-5

Weitere Artikel der Ausgabe 7/2016

Intensive Care Medicine 7/2016 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.